Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

CGBL vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, CGBL returned +7.1% to XBI's +41.2%, and CGBL charges 0.33% to XBI's 0.35%.

askIQ about this page

askIQ about CGBL and XBI

Net assets on Oct 27, 2026: $7.9bn for Capital Group Core Balanced ETF and $10.3bn for State Street SPDR S&P Biotech ETF.

At a glance
+7.1%
CGBL total return, 1 year
+41.2%
XBI total return, 1 year
0.33%
CGBL expense ratio
0.35%
XBI expense ratio

Pair scorecard

CGBL costs 0.02 points a year less; their one-year returns differ by 34.1 points; XBI is 1.3 times larger.

CGBL vs XBI: Differences, Returns & Fees
MeasureCGBLXBI
Return
Total return, 1 year+7.1%+41.2%
Drawdown
Below its high3.4%, high on Aug 13, 2026
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksNo index, actively managedBiotech
Cost and size
Expense ratio0.33%0.35%
Net assets, as of Oct 27, 2026$7.9bn$10.3bn
Active share vs the S&P 50098%
Holdings
Holdings in common3%
Top ten holdings, share of the fund59.3%18%

Holdings in common uses holdings dated Jun 30, 2026 and Oct 27, 2026. Method

What they share

3%

By the books each fund has filed, CGBL and XBI hold 3% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Oct 27, 2026.

0 half 100%

half

3% in common

Positions both hold · largest shared weight first CGBL XBI
Vertex Pharmaceuticals Inc 1.20% 1.46%
Gilead Sciences Inc 0.74% 1.60%
Amgen Inc 0.54% 1.68%
Alnylam Pharmaceuticals Inc 0.52% 1.29%
Only in one fund ↓
Only in CGBL
Capital Group Core Plus Income ETF 23.27%
Capital Group Core Bond ETF 15.64%
Broadcom Inc 4.58%
Taiwan Semiconductor Manufacturing Co Ltd 3.49%
Alphabet Inc 2.79%
Micron Technology Inc 2.23%
Philip Morris International Inc 2.07%
Apple Inc 2.01%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
ABBVIE INC 1.67%
SPYRE THERAPEUTICS INC 1.67%
Check overlap with more funds →

Side by side

CGBL Capital Group Core Balanced ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Allocation ETF Thematic ETF
What it is Actively managed Biotech
Total return, 1 year +7.1% +41.2%
Its benchmark over the same days +7.5% (VOO and AGG) not measured
Gap to its benchmark −0.4 pts vs VOO and AGG not measured
Expense ratio 0.33% 0.35%
Already in the S&P 500 48.1% 13.2%
Holdings 77 165
Net assets, as of Oct 27, 2026 $7.9bn $10.3bn

CGBL and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
CGBL

Over the year to Oct 28, 2026 it returned +7.1% with distributions reinvested, against +7.5% for its benchmark, the 60%/40% S&P 500 Index/Bloomberg U.S. Aggregate Index.

CGBL is actively managed and tracks no index. The prospectus expense ratio is 0.33% a year. By its holdings filed for Jun 30, 2026, 48% of the fund by weight is stocks the S&P 500 also holds, across 77 positions, with the top ten at 59.3%. It sat 3.4% below its high of Aug 13, 2026 on Oct 28, 2026.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are CGBL and XBI in the same category?
CGBL is an allocation ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, CGBL or XBI?
In the year to Oct 28, 2026, with distributions reinvested, CGBL returned +7.1% and XBI +41.2%.
Which is cheaper, CGBL or XBI?
CGBL is cheaper, by 0.02 percentage points a year. That is about $2 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do CGBL and XBI overlap with the S&P 500?
By their latest filed holdings, 48% of CGBL and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, CGBL against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/cgbl-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.